FDA approves Cobenfy for adults with schizophrenia
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...
Managed Healthcare Executive4h
VA Adds Cancer Immunotherapy Monjuvi to National Formulary
Monjuvi is available under an accelerated approval to treat adults with relapsed or refractory diffuse large B-cell lymphoma.
Scientific Research Publishing13h
Impact of Market Economy on Health: Global View from Türkiye’s Perspective and the Role of WHO ()
The USA is again at the top of the table, with $12,550 per capita spent on health. It is followed by Switzerland, with $8050, and Norway, with $7771. The OECD average is 4500 dollars, which is at ...
Le Lézard3h
VBI Vaccines Issues Voluntary Nationwide Recall of all PreHevbrio Vaccine Due to Discontinuation of Company Operations
C-36, as amended (the "CCAA Proceeding") on July 29, 2024, in the Superior Court of Justice (Commercial List) in Ontario ... The U.S. Food and Drug Administration is aware that VBI has permanently ...